-
HPA003124-100
Anti-FANCB Fanconi anemia, complementation group B, 100ul UN
Price: $1,108.10List Price: $1,231.23Anti-FANCB Fanconi anemia, complementation group B, 100ul UN -
-
-
-
-
-
-
-
T647305-10mg
Tovinontrine (C007B-430486)
Price: $730.82List Price: $812.03Tovinontrine (IMR-687) is a highly potent and selective phosphodiesterase-9 (PDE9) inhibitor specifically for the treatment of sickle cell disease. IC 50 s are 8.19 nM and 9.99 nM for PDE9A1 and PDE9A2, respectivelyIn VitroIMR-687 inhibits PDE9A -
T647305-25mg
Tovinontrine (C007B-430487)
Price: $1,399.74List Price: $1,555.27Tovinontrine (IMR-687) is a highly potent and selective phosphodiesterase-9 (PDE9) inhibitor specifically for the treatment of sickle cell disease. IC 50 s are 8.19 nM and 9.99 nM for PDE9A1 and PDE9A2, respectivelyIn VitroIMR-687 inhibits PDE9A -
T647305-5mg
Tovinontrine (C007B-430488)
Price: $492.33List Price: $547.03Tovinontrine (IMR-687) is a highly potent and selective phosphodiesterase-9 (PDE9) inhibitor specifically for the treatment of sickle cell disease. IC 50 s are 8.19 nM and 9.99 nM for PDE9A1 and PDE9A2, respectivelyIn VitroIMR-687 inhibits PDE9A -
T654973-1ml
Tovinontrine (C007B-431375)
Price: $541.44List Price: $601.60Tovinontrine (IMR-687) is a highly potent and selective phosphodiesterase-9 (PDE9) inhibitor specifically for the treatment of sickle cell disease. IC 50 s are 8.19 nM and 9.99 nM for PDE9A1 and PDE9A2, respectivelyIn VitroIMR-687 inhibits PDE9A